|
|
|
With its international funding and expertise the Institut Laue-Langevin (ILL) offers scientists and industry the world's leading facility in neutron science and technology. From its Grenoble site in the south-east of France the Institute operates the most intense neutron source on earth.

30.09.2011 A new technique for understanding quantum effects in waterUse of oxygen isotope substitution will lead to more accurate structural modelling of oxide materials found in everything from biological processes to electronic devices. A publication in Physical Review letters. It covers...[more] 26.09.2011 ESS and ILL start joint R&D in neutron scienceToday, 26th September, the European Spallation Source and the ILL initiate an extensive collaboration for research and development activities within neutron science.In a Memorandum of Understanding agreed on today, ILL and ESS...[more] 21.09.2011 A new UCNs source at ILLNew source of super-chilled neutrons provides tools for understanding fundamental physics conceptsResearch into fundamental constants of nature and the search for new particles will benefit from new production method for...[more] 20.09.2011 The ILL and ESRF BDOs at the Montpellier EUROMAT fairFrom 12 to 15 September 2011, ILL and ESRF shared a stand in the European Congress and Exhibition on advanced Materials and Processes (EUROMAT 2011). [more] 19.09.2011 More than 700 proposalsWe have received more than 700 experiments proposals during the last round. They will be reviewed by the scientifc subcommittees on 15 & 16 November. http://club.ill.fr/cv/ [more] 19.08.2011 Photoreactive Surfactants: A Facile and Clean Route to Oxide and Metal Nanoparticles in Reverse MicellesA new paper from Eastoe, Grillo et al highlighted in the ACS Noteworthy Chemistry. The experiments were carried out at ILL on D22. [more] 19.07.2011 Precise measurements of cholesterol transport rates give new hope for Alzheimer’s treatmentNeutrons have shown the movement of cholesterol between and within cells takes far longer than previously thought. Findings could impact the treatment of a range of diseases linked to abnormal rates of cholesterol...[more] |